nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—ALB—Levothyroxine—hypothyroidism	0.133	0.157	CbGbCtD
Vismodegib—ALB—Liothyronine—hypothyroidism	0.133	0.157	CbGbCtD
Vismodegib—ALB—Liotrix—hypothyroidism	0.13	0.153	CbGbCtD
Vismodegib—CYP2C8—Levothyroxine—hypothyroidism	0.103	0.121	CbGbCtD
Vismodegib—CYP2C8—Liotrix—hypothyroidism	0.1	0.118	CbGbCtD
Vismodegib—ABCB1—Levothyroxine—hypothyroidism	0.0696	0.0821	CbGbCtD
Vismodegib—ABCB1—Liothyronine—hypothyroidism	0.0696	0.0821	CbGbCtD
Vismodegib—ABCB1—Liotrix—hypothyroidism	0.0679	0.0801	CbGbCtD
Vismodegib—CYP3A4—Levothyroxine—hypothyroidism	0.0417	0.0492	CbGbCtD
Vismodegib—CYP2C19—urine—hypothyroidism	0.00533	0.0686	CbGeAlD
Vismodegib—SMO—adrenal cortex—hypothyroidism	0.00458	0.0589	CbGeAlD
Vismodegib—SMO—heart—hypothyroidism	0.00443	0.057	CbGeAlD
Vismodegib—CYP2C9—urine—hypothyroidism	0.00413	0.0532	CbGeAlD
Vismodegib—SMO—pituitary gland—hypothyroidism	0.0037	0.0476	CbGeAlD
Vismodegib—SHH—cerebellum—hypothyroidism	0.00361	0.0464	CbGeAlD
Vismodegib—SMO—adrenal gland—hypothyroidism	0.0033	0.0425	CbGeAlD
Vismodegib—SMO—thyroid gland—hypothyroidism	0.00319	0.041	CbGeAlD
Vismodegib—CYP3A4—urine—hypothyroidism	0.00315	0.0406	CbGeAlD
Vismodegib—Blood urea increased—Liotrix—hypothyroidism	0.00311	0.0452	CcSEcCtD
Vismodegib—SMO—female gonad—hypothyroidism	0.00308	0.0397	CbGeAlD
Vismodegib—Dehydration—Levothyroxine—hypothyroidism	0.00302	0.0439	CcSEcCtD
Vismodegib—Dehydration—Dextrothyroxine—hypothyroidism	0.00302	0.0439	CcSEcCtD
Vismodegib—SMO—testis—hypothyroidism	0.00273	0.0352	CbGeAlD
Vismodegib—SMO—liver—hypothyroidism	0.00258	0.0333	CbGeAlD
Vismodegib—Weight decreased—Levothyroxine—hypothyroidism	0.00254	0.0369	CcSEcCtD
Vismodegib—Weight decreased—Dextrothyroxine—hypothyroidism	0.00254	0.0369	CcSEcCtD
Vismodegib—SMO—cerebellum—hypothyroidism	0.00252	0.0325	CbGeAlD
Vismodegib—Dehydration—Liotrix—hypothyroidism	0.00222	0.0323	CcSEcCtD
Vismodegib—Hypokalaemia—Liotrix—hypothyroidism	0.00217	0.0316	CcSEcCtD
Vismodegib—Alopecia—Dextrothyroxine—hypothyroidism	0.00199	0.0289	CcSEcCtD
Vismodegib—Alopecia—Levothyroxine—hypothyroidism	0.00199	0.0289	CcSEcCtD
Vismodegib—Weight decreased—Liotrix—hypothyroidism	0.00187	0.0272	CcSEcCtD
Vismodegib—ALB—heart—hypothyroidism	0.0017	0.0218	CbGeAlD
Vismodegib—Arthralgia—Levothyroxine—hypothyroidism	0.00167	0.0242	CcSEcCtD
Vismodegib—Arthralgia—Dextrothyroxine—hypothyroidism	0.00167	0.0242	CcSEcCtD
Vismodegib—Alopecia—Liotrix—hypothyroidism	0.00146	0.0212	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00145	0.0212	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00145	0.0212	CcSEcCtD
Vismodegib—ORM1—blood—hypothyroidism	0.00144	0.0186	CbGeAlD
Vismodegib—Dysgeusia—Liotrix—hypothyroidism	0.00141	0.0205	CcSEcCtD
Vismodegib—Fatigue—Levothyroxine—hypothyroidism	0.00138	0.02	CcSEcCtD
Vismodegib—Fatigue—Dextrothyroxine—hypothyroidism	0.00138	0.02	CcSEcCtD
Vismodegib—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00131	0.019	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00131	0.019	CcSEcCtD
Vismodegib—SHH—Differentiation Pathway—TPO—hypothyroidism	0.00128	0.218	CbGpPWpGaD
Vismodegib—ALB—adrenal gland—hypothyroidism	0.00127	0.0163	CbGeAlD
Vismodegib—Abdominal pain—Levothyroxine—hypothyroidism	0.00126	0.0184	CcSEcCtD
Vismodegib—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00126	0.0184	CcSEcCtD
Vismodegib—Arthralgia—Liotrix—hypothyroidism	0.00123	0.0178	CcSEcCtD
Vismodegib—ABCG2—adrenal cortex—hypothyroidism	0.0012	0.0154	CbGeAlD
Vismodegib—ABCG2—heart—hypothyroidism	0.00116	0.0149	CbGeAlD
Vismodegib—Asthenia—Dextrothyroxine—hypothyroidism	0.00115	0.0167	CcSEcCtD
Vismodegib—Asthenia—Levothyroxine—hypothyroidism	0.00115	0.0167	CcSEcCtD
Vismodegib—Pruritus—Dextrothyroxine—hypothyroidism	0.00113	0.0164	CcSEcCtD
Vismodegib—Pruritus—Levothyroxine—hypothyroidism	0.00113	0.0164	CcSEcCtD
Vismodegib—ORM1—liver—hypothyroidism	0.00113	0.0145	CbGeAlD
Vismodegib—Diarrhoea—Levothyroxine—hypothyroidism	0.00109	0.0159	CcSEcCtD
Vismodegib—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00109	0.0159	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00107	0.0156	CcSEcCtD
Vismodegib—CYP2C9—heart—hypothyroidism	0.00106	0.0136	CbGeAlD
Vismodegib—ALB—testis—hypothyroidism	0.00105	0.0135	CbGeAlD
Vismodegib—SHH—Heart Development—NKX2-5—hypothyroidism	0.00104	0.177	CbGpPWpGaD
Vismodegib—Decreased appetite—Liotrix—hypothyroidism	0.00102	0.0148	CcSEcCtD
Vismodegib—CYP2C19—blood—hypothyroidism	0.00102	0.0131	CbGeAlD
Vismodegib—Vomiting—Levothyroxine—hypothyroidism	0.00102	0.0148	CcSEcCtD
Vismodegib—Vomiting—Dextrothyroxine—hypothyroidism	0.00102	0.0148	CcSEcCtD
Vismodegib—Fatigue—Liotrix—hypothyroidism	0.00101	0.0147	CcSEcCtD
Vismodegib—Rash—Dextrothyroxine—hypothyroidism	0.00101	0.0146	CcSEcCtD
Vismodegib—Rash—Levothyroxine—hypothyroidism	0.00101	0.0146	CcSEcCtD
Vismodegib—Dermatitis—Levothyroxine—hypothyroidism	0.00101	0.0146	CcSEcCtD
Vismodegib—Dermatitis—Dextrothyroxine—hypothyroidism	0.00101	0.0146	CcSEcCtD
Vismodegib—Constipation—Liotrix—hypothyroidism	0.001	0.0146	CcSEcCtD
Vismodegib—CYP2C9—cardiovascular system—hypothyroidism	0.000999	0.0129	CbGeAlD
Vismodegib—CYP2C8—pituitary gland—hypothyroidism	0.000996	0.0128	CbGeAlD
Vismodegib—ALB—liver—hypothyroidism	0.00099	0.0127	CbGeAlD
Vismodegib—ABCG2—pituitary gland—hypothyroidism	0.000968	0.0125	CbGeAlD
Vismodegib—Gastrointestinal pain—Liotrix—hypothyroidism	0.00096	0.014	CcSEcCtD
Vismodegib—Nausea—Levothyroxine—hypothyroidism	0.000948	0.0138	CcSEcCtD
Vismodegib—Nausea—Dextrothyroxine—hypothyroidism	0.000948	0.0138	CcSEcCtD
Vismodegib—Abdominal pain—Liotrix—hypothyroidism	0.000928	0.0135	CcSEcCtD
Vismodegib—CYP2C8—blood—hypothyroidism	0.000889	0.0115	CbGeAlD
Vismodegib—ABCG2—adrenal gland—hypothyroidism	0.000865	0.0111	CbGeAlD
Vismodegib—ABCG2—blood—hypothyroidism	0.000865	0.0111	CbGeAlD
Vismodegib—Asthenia—Liotrix—hypothyroidism	0.000843	0.0123	CcSEcCtD
Vismodegib—ABCG2—thyroid gland—hypothyroidism	0.000835	0.0107	CbGeAlD
Vismodegib—Pruritus—Liotrix—hypothyroidism	0.000831	0.0121	CcSEcCtD
Vismodegib—ABCG2—female gonad—hypothyroidism	0.000806	0.0104	CbGeAlD
Vismodegib—Diarrhoea—Liotrix—hypothyroidism	0.000804	0.0117	CcSEcCtD
Vismodegib—CYP2C19—liver—hypothyroidism	0.000797	0.0103	CbGeAlD
Vismodegib—CYP2C9—blood—hypothyroidism	0.00079	0.0102	CbGeAlD
Vismodegib—Vomiting—Liotrix—hypothyroidism	0.000747	0.0109	CcSEcCtD
Vismodegib—Rash—Liotrix—hypothyroidism	0.000741	0.0108	CcSEcCtD
Vismodegib—Dermatitis—Liotrix—hypothyroidism	0.00074	0.0108	CcSEcCtD
Vismodegib—CYP2C8—testis—hypothyroidism	0.000736	0.00947	CbGeAlD
Vismodegib—ABCG2—testis—hypothyroidism	0.000715	0.00921	CbGeAlD
Vismodegib—Nausea—Liotrix—hypothyroidism	0.000698	0.0101	CcSEcCtD
Vismodegib—CYP2C8—liver—hypothyroidism	0.000695	0.00896	CbGeAlD
Vismodegib—ABCG2—liver—hypothyroidism	0.000676	0.00871	CbGeAlD
Vismodegib—ABCG2—cerebellum—hypothyroidism	0.000661	0.00851	CbGeAlD
Vismodegib—CYP2C9—liver—hypothyroidism	0.000618	0.00796	CbGeAlD
Vismodegib—CYP3A4—blood—hypothyroidism	0.000602	0.00776	CbGeAlD
Vismodegib—ABCB1—adrenal cortex—hypothyroidism	0.000591	0.00761	CbGeAlD
Vismodegib—ABCB1—heart—hypothyroidism	0.000571	0.00736	CbGeAlD
Vismodegib—ABCB1—cardiovascular system—hypothyroidism	0.000539	0.00694	CbGeAlD
Vismodegib—ABCB1—gonad—hypothyroidism	0.000489	0.0063	CbGeAlD
Vismodegib—ABCB1—pituitary gland—hypothyroidism	0.000477	0.00615	CbGeAlD
Vismodegib—CYP3A4—liver—hypothyroidism	0.000471	0.00607	CbGeAlD
Vismodegib—ABCB1—adrenal gland—hypothyroidism	0.000426	0.00549	CbGeAlD
Vismodegib—ABCB1—blood—hypothyroidism	0.000426	0.00549	CbGeAlD
Vismodegib—ABCB1—thyroid gland—hypothyroidism	0.000412	0.0053	CbGeAlD
Vismodegib—ABCB1—female gonad—hypothyroidism	0.000398	0.00512	CbGeAlD
Vismodegib—ABCB1—testis—hypothyroidism	0.000353	0.00454	CbGeAlD
Vismodegib—ABCB1—liver—hypothyroidism	0.000333	0.00429	CbGeAlD
Vismodegib—ABCB1—cerebellum—hypothyroidism	0.000326	0.00419	CbGeAlD
Vismodegib—SHH—Differentiation Pathway—IGF1—hypothyroidism	0.000224	0.038	CbGpPWpGaD
Vismodegib—ALB—Transport of organic anions—AVP—hypothyroidism	0.000167	0.0284	CbGpPWpGaD
Vismodegib—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000145	0.0246	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—TRH—hypothyroidism	0.000113	0.0192	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—TRH—hypothyroidism	0.000107	0.0182	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—TSHB—hypothyroidism	0.000101	0.0171	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—TSHR—hypothyroidism	0.000101	0.0171	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—TSHB—hypothyroidism	9.56e-05	0.0162	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—TSHR—hypothyroidism	9.56e-05	0.0162	CbGpPWpGaD
Vismodegib—SHH—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.41e-05	0.0126	CbGpPWpGaD
Vismodegib—SMO—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	7.02e-05	0.0119	CbGpPWpGaD
Vismodegib—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	6.19e-05	0.0105	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—AVP—hypothyroidism	5.94e-05	0.0101	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—TRH—hypothyroidism	5.81e-05	0.00987	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—AVP—hypothyroidism	5.63e-05	0.00958	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—TRH—hypothyroidism	5.5e-05	0.00935	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—TSHB—hypothyroidism	5.18e-05	0.00879	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—TSHR—hypothyroidism	5.18e-05	0.00879	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—TSHR—hypothyroidism	4.91e-05	0.00834	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—TSHB—hypothyroidism	4.91e-05	0.00834	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	4.22e-05	0.00718	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CLTC—hypothyroidism	3.97e-05	0.00674	CbGpPWpGaD
Vismodegib—SHH—GPCR ligand binding—POMC—hypothyroidism	3.95e-05	0.00671	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CLTC—hypothyroidism	3.76e-05	0.00639	CbGpPWpGaD
Vismodegib—SMO—GPCR ligand binding—POMC—hypothyroidism	3.74e-05	0.00636	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	3.5e-05	0.00595	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	3.48e-05	0.00591	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TRH—hypothyroidism	3.43e-05	0.00583	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TRH—hypothyroidism	3.25e-05	0.00553	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—VAV3—hypothyroidism	3.17e-05	0.00538	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TSHB—hypothyroidism	3.06e-05	0.0052	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TSHR—hypothyroidism	3.06e-05	0.0052	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—AVP—hypothyroidism	3.05e-05	0.00518	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—VAV3—hypothyroidism	3e-05	0.0051	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TSHB—hypothyroidism	2.9e-05	0.00493	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TSHR—hypothyroidism	2.9e-05	0.00493	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—AVP—hypothyroidism	2.89e-05	0.00491	CbGpPWpGaD
Vismodegib—SHH—Disease—PRL—hypothyroidism	2.89e-05	0.00491	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	2.88e-05	0.0049	CbGpPWpGaD
Vismodegib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.87e-05	0.00488	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SH2B3—hypothyroidism	2.72e-05	0.00463	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—SH2B3—hypothyroidism	2.58e-05	0.00439	CbGpPWpGaD
Vismodegib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.56e-05	0.00436	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—IYD—hypothyroidism	2.35e-05	0.004	CbGpPWpGaD
Vismodegib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	2.34e-05	0.00397	CbGpPWpGaD
Vismodegib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.33e-05	0.00396	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—IGF1—hypothyroidism	2.18e-05	0.00371	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	2.15e-05	0.00365	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	2.08e-05	0.00353	CbGpPWpGaD
Vismodegib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	2.08e-05	0.00353	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—POMC—hypothyroidism	2.03e-05	0.00344	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—PRL—hypothyroidism	2.02e-05	0.00344	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ATP5O—hypothyroidism	2e-05	0.0034	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—POMC—hypothyroidism	1.92e-05	0.00327	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—PRL—hypothyroidism	1.92e-05	0.00326	CbGpPWpGaD
Vismodegib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.89e-05	0.00322	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	1.88e-05	0.0032	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TPO—hypothyroidism	1.88e-05	0.00319	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VAV3—hypothyroidism	1.87e-05	0.00318	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—AVP—hypothyroidism	1.8e-05	0.00306	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.78e-05	0.00302	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VAV3—hypothyroidism	1.77e-05	0.00301	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—AVP—hypothyroidism	1.71e-05	0.0029	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	1.69e-05	0.00287	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	1.57e-05	0.00267	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	1.56e-05	0.00265	CbGpPWpGaD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	1.54e-05	0.00262	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—IYD—hypothyroidism	1.46e-05	0.00248	CbGpPWpGaD
Vismodegib—ALB—Metabolism—IYD—hypothyroidism	1.45e-05	0.00247	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	1.39e-05	0.00236	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	1.33e-05	0.00226	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—IYD—hypothyroidism	1.3e-05	0.00221	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—IYD—hypothyroidism	1.27e-05	0.00216	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	1.25e-05	0.00212	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ATP5O—hypothyroidism	1.24e-05	0.00211	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—POMC—hypothyroidism	1.24e-05	0.0021	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ATP5O—hypothyroidism	1.23e-05	0.0021	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—POMC—hypothyroidism	1.2e-05	0.00203	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—IYD—hypothyroidism	1.19e-05	0.00202	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SH2B3—hypothyroidism	1.18e-05	0.00201	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TPO—hypothyroidism	1.17e-05	0.00198	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TPO—hypothyroidism	1.16e-05	0.00197	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—IGF1—hypothyroidism	1.15e-05	0.00196	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—POMC—hypothyroidism	1.14e-05	0.00193	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ATP5O—hypothyroidism	1.11e-05	0.00188	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—POMC—hypothyroidism	1.1e-05	0.00188	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—AVP—hypothyroidism	1.09e-05	0.00186	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—IGF1—hypothyroidism	1.09e-05	0.00186	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ATP5O—hypothyroidism	1.08e-05	0.00184	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.08e-05	0.00184	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	1.07e-05	0.00183	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TPO—hypothyroidism	1.04e-05	0.00177	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TPO—hypothyroidism	1.02e-05	0.00173	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ATP5O—hypothyroidism	1.01e-05	0.00172	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—POMC—hypothyroidism	1.01e-05	0.00171	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	9.68e-06	0.00164	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.65e-06	0.00164	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	9.53e-06	0.00162	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TPO—hypothyroidism	9.49e-06	0.00161	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.8e-06	0.00149	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TSHB—hypothyroidism	8.7e-06	0.00148	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.58e-06	0.00146	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VAV3—hypothyroidism	8.1e-06	0.00138	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—IYD—hypothyroidism	7.83e-06	0.00133	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PIK3C2A—hypothyroidism	7.76e-06	0.00132	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.52e-06	0.00128	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	6.76e-06	0.00115	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ATP5O—hypothyroidism	6.66e-06	0.00113	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—POMC—hypothyroidism	6.64e-06	0.00113	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—SLC5A5—hypothyroidism	6.51e-06	0.00111	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TPO—hypothyroidism	6.26e-06	0.00106	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.92e-06	0.00101	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TSHB—hypothyroidism	5.4e-06	0.000918	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TSHB—hypothyroidism	5.37e-06	0.000912	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—IGF1—hypothyroidism	4.99e-06	0.000848	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TSHB—hypothyroidism	4.82e-06	0.000819	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PIK3C2A—hypothyroidism	4.81e-06	0.000818	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PIK3C2A—hypothyroidism	4.79e-06	0.000813	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.75e-06	0.000807	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.72e-06	0.000802	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TSHB—hypothyroidism	4.7e-06	0.000799	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TSHB—hypothyroidism	4.39e-06	0.000747	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	4.3e-06	0.00073	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.24e-06	0.00072	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PIK3C2A—hypothyroidism	4.19e-06	0.000713	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—SLC5A5—hypothyroidism	4.04e-06	0.000687	CbGpPWpGaD
Vismodegib—ALB—Metabolism—SLC5A5—hypothyroidism	4.02e-06	0.000683	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	3.92e-06	0.000666	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.87e-06	0.000657	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—SLC5A5—hypothyroidism	3.61e-06	0.000613	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—SLC5A5—hypothyroidism	3.52e-06	0.000598	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—POMC—hypothyroidism	3.41e-06	0.000579	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—SLC5A5—hypothyroidism	3.29e-06	0.000559	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TSHB—hypothyroidism	2.9e-06	0.000493	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.58e-06	0.000439	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.17e-06	0.000369	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—POMC—hypothyroidism	2.11e-06	0.000359	CbGpPWpGaD
Vismodegib—ALB—Metabolism—POMC—hypothyroidism	2.1e-06	0.000357	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—POMC—hypothyroidism	1.89e-06	0.000321	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—POMC—hypothyroidism	1.84e-06	0.000313	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—POMC—hypothyroidism	1.72e-06	0.000293	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—POMC—hypothyroidism	1.14e-06	0.000193	CbGpPWpGaD
